Apolipoprotein E (ApoE) genotyping has been shown to have diagnostic value in the evaluation of cardiovascular diseases and neurodegenerative disorders such as Alzheimer’s disease. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.